Minnetonka Inc said thatneither its Foltene hair treatment nor its European supplier,Crinos Industria Farmacobiologica SpA, are named or involved inaction filed by Upjohn Co.    Earlier today, Upjohn said it filed a complaint with theInternational Trade Commission requesting an investigation ofinfringement of its patent for the drug, Minoxidil, used in itstreatment for baldness.    Minnetonka said it decided to make a statement to "dispellany association it may be involved" with the suit. Foltene doesnot use compositions of Minoxidil, it said. Reuter&#3;